Mobile

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety of MK-0431 Monotherapy in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Contr...

Mise à jour : Il y a 5 ans
Référence : EUCTR2004-002160-22

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety of MK-0431 Monotherapy in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Control

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

In patients with type 2 diabetes mellitus and chronic renal insufficiency with inadequate glycemic control Primary: To assess the safety and tolerability of MK-0431 after 12 weeks.

Critère d'inclusion

  • Type 2 diabetes mellitus,Chronic Renal Insufficiency [MedDRA classification code: 10050441]

Liens